| Name | Osco Pharmacy #4040 |
|---|---|
| Organization Name | Albertsons Llc |
| Location | 1313 N 1st St, Hamilton, Montana 59840 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (406) 363-7089 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Patients with blood cancers such as leukemia and lymphoma are often treated by irradiating their bone marrow to destroy the diseased cells. After the treatment, patients are vulnerable to infection and fatigue until new blood cells grow back.
These "policy riders" restrict spending on certain social and regulatory initiatives, including implementation of the health law and funding for Planned Parenthood. These contentious issues are becoming as difficult to resolve as reaching agreement on a final figure for spending cuts.
While the world has its eyes on vaccines to stop the spread of coronavirus, therapeutics are still necessary to treat hospitalized patients. One of these treatments, remdesivir, is the first and only antiviral agent of its kind that the U.S. Food and Drug Administration (FDA) has approved so far for COVID-19.
Several presentations by deCODE genetics scientists and independent researchers at the American Heart Association Scientific Sessions 2008 being held at the New Orleans Convention Center from November 8 to12 are expected to expand upon the clinical utility of evaluating individual risk of heart attack, or atrial fibrillation and stroke, respectively, by measuring the genetic markers that are the basis of the deCODE MI and deCODE AF tests.
› Verified 2 days ago
| NPI Number | 1700832359 |
| Organization Name | ALBERTSONS LLC |
| Doing Business As | OSCO PHARMACY #4040 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1313 N 1st St, Hamilton, MT 59840 |
| Phone Number | 406-363-7089 |
News Archive
Patients with blood cancers such as leukemia and lymphoma are often treated by irradiating their bone marrow to destroy the diseased cells. After the treatment, patients are vulnerable to infection and fatigue until new blood cells grow back.
These "policy riders" restrict spending on certain social and regulatory initiatives, including implementation of the health law and funding for Planned Parenthood. These contentious issues are becoming as difficult to resolve as reaching agreement on a final figure for spending cuts.
While the world has its eyes on vaccines to stop the spread of coronavirus, therapeutics are still necessary to treat hospitalized patients. One of these treatments, remdesivir, is the first and only antiviral agent of its kind that the U.S. Food and Drug Administration (FDA) has approved so far for COVID-19.
Several presentations by deCODE genetics scientists and independent researchers at the American Heart Association Scientific Sessions 2008 being held at the New Orleans Convention Center from November 8 to12 are expected to expand upon the clinical utility of evaluating individual risk of heart attack, or atrial fibrillation and stroke, respectively, by measuring the genetic markers that are the basis of the deCODE MI and deCODE AF tests.
› Verified 2 days ago
News Archive
Patients with blood cancers such as leukemia and lymphoma are often treated by irradiating their bone marrow to destroy the diseased cells. After the treatment, patients are vulnerable to infection and fatigue until new blood cells grow back.
These "policy riders" restrict spending on certain social and regulatory initiatives, including implementation of the health law and funding for Planned Parenthood. These contentious issues are becoming as difficult to resolve as reaching agreement on a final figure for spending cuts.
While the world has its eyes on vaccines to stop the spread of coronavirus, therapeutics are still necessary to treat hospitalized patients. One of these treatments, remdesivir, is the first and only antiviral agent of its kind that the U.S. Food and Drug Administration (FDA) has approved so far for COVID-19.
Several presentations by deCODE genetics scientists and independent researchers at the American Heart Association Scientific Sessions 2008 being held at the New Orleans Convention Center from November 8 to12 are expected to expand upon the clinical utility of evaluating individual risk of heart attack, or atrial fibrillation and stroke, respectively, by measuring the genetic markers that are the basis of the deCODE MI and deCODE AF tests.
› Verified 2 days ago
Healthcare Providers Type: Long Term Care Pharmacy Location: 1900 North 1st Street, Hamilton, Montana 59840 Phone: (406) 363-0841 | |
Bitterroot Drug Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 211 W Main St, Hamilton, Montana 59840 Phone: (406) 363-3611 | |
Osco Pharmacy #4040 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1313 N 1st St, Hamilton, Montana 59840 Phone: (406) 363-7089 | |
Timber Ridge Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1131 N 1st St, Hamilton, Montana 59840 Phone: (406) 363-9003 | |
Norco Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1001 N 1st St, Hamilton, Montana 59840 Phone: (406) 363-1800 |